I believe there are similar class action rulings for settling purposes, but I agree that this seems to be the first ruling regarding New Jersey's CFA anywhere for a litigation class.
He would not have had this heart attack if it had not been for this drug,
He shouldn't be testifying, ... He's got the appearance of being somebody who was there on the scene. He wasn't there.
Merck calculated cardiovascular warnings would cost the company 50 percent of its profits through 2006.
We are trying the case on the science,
What you've seen from Merck is really nothing more than an act of desperation. When you have no science, you attack the victim.
Was it all given? In some cases, I have to say yes. But was it given in a way that they could understand? No.
When you have the evidence, you have to test it, and you test it before you put a single pill into a human.
When I started this trial, I thought we were going to try this case on science. I had no idea my client would be called a liar.
Don't let them come in here and fool us, ... when they have this attitude about the FDA and then hide behind the FDA.
It's about marketing over science. We're going to show that the company knew all about the risks before they sold the drug. We're going to force them to defend the case on the science.
I'm not calling anybody in this room a murderer or killer. I'm not talking about anybody's kids, ... Do we need pharmaceutical companies? Of course we do. But this was a pain pill.
I had no idea my client would be called a liar and attacked.